相关实验视频

Updated: Jul 18, 2025

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

在大脑中c-Abl Tyrosine Kinase的作用及其病理

Helena Motaln¹, Boris Rogelj^1,2

¹Department of Biotechnology, Jozef Stefan Institute, 1000 Ljubljana, Slovenia.

|August 26, 2023

概括

神经退行性疾病与神经元中的细胞死亡有关. 这项研究探讨了阿贝尔森酶 (c-Abl) 信号如何促进神经退行,表明c-Abl抑制是潜在的治疗策略.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

神经组织由于其差异化状态和有限的再生,容易受到细胞死亡的影响.
神经退行性疾病很普遍,特别是在老年人中,强调需要了解细胞死亡机制.
激酶是细胞平衡的关键调节者,异常信号通路与神经退行有关.

研究的目的:

研究非受体氨酸激酶c-Abl在正常神经发育和神经退行性病理中的作用.
阐明c-Abl调解神经退行的分子机制,重点关注压力信号,DNA损伤和代谢调节.
探索c-Abl抑制作为神经退行性疾病治疗方法的潜力.

主要方法:

关于c-Abl参与神经组织的最新发现的综述.
专注于神经元,星细胞和微质细胞中的分子事件.
分析压力信号,DNA损伤和代谢调节之间的相互作用.

主要成果:

异常表达或c-Abl的激活与神经退行性病理有关.
c-Abl 在正常的神经发育和疾病进展中发挥作用.
抑制c-Abl表现出神经保护作用,并防止神经元死亡.

结论:

c-Abl信号传递是神经退行症进展的关键因素.
了解c-Abl在应激反应,DNA损伤和新陈代谢中的作用是关键.
准c-Abl为治疗神经退行性疾病提供了一个有前途的治疗途径.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.帕金森病是帕金森氏症的一种疾病.c-Abl (阿贝尔森) 铁氨酸激酶激酶信号传递中的激酶信号.神经退行症的神经退行症

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

相关概念视频

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

The Blood-brain Barrier

The Blood-brain Barrier

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...